Stock listing

Frankfurt:2I3 Champions Oncology, Inc. Aktie

German listing (Frankfurt) of Champions Oncology, Inc. · home listing NASDAQ:CSBR

Follow Champions Oncology, Inc. into a list and get an email when it puts out news.

Share price · FWB:2I3

€4.20 EUR -0.04 (-0.9%)

Close on Oct 30, 2026

Day range
€4.16 – €4.20 EUROct 30, 2026
Market cap
€58.46M EURAt the close on Oct 30, 2026 · price × 13.92M shares outstanding
Champions Oncology, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CSBR · Home$4.81 USD0.00 (0.0%)12,963$4.98$5.03$4.77$4.81Close on Nov 2, 2026
Frankfurt:2I3€4.20 EUR-0.04 (-0.9%)—€4.16€4.20€4.16€4.24Close on Oct 30, 2026
Ticker
Frankfurt:2I3
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Champions Oncology (NASDAQ:CSBR) Q4 2026 Earnings Call

    Mon, Jul 27, 2026 · 4:30 PM ET

    Watch Transcript
  • Champions Oncology (NASDAQ:CSBR) Q3 2026 Earnings Call

    Thu, Mar 12, 2026 · 4:30 PM ET

    Watch Transcript
  • Champions Oncology (NASDAQ:CSBR) Q2 2026 Earnings Call

    Mon, Dec 15, 2025 · 4:30 PM ET

    Watch Transcript

Latest news

All Champions Oncology, Inc. news

Decks

Champions Oncology, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
9 in the last 12 months · 95 in all · newest Sep 10, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Jul 27, 2026
Decks
9 decks · latest March 2021

Where Champions Oncology, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CSBR · Home listingNASDAQUnited StatesUSD
LS Exchange:A14X6SLS ExchangeGermanyEUR
BOATS:CSBRBOATSUnited StatesUSD
gettex:2I3gettexGermanyEUR
Dusseldorf:2I3DusseldorfGermanyEUR
Frankfurt:2I3 · This pageFrankfurtGermanyEUR
Lang & Schwarz:A14X6SLang & SchwarzGermanyEUR
Munich:2I3MunichGermanyEUR
Stuttgart:2I3StuttgartGermanyEUR
Tradegate:2I3TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Champions Oncology, Inc.